BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9216008)

  • 1. Reproducibility of vitreous fluorophotometry in patients with type 1 diabetes mellitus.
    Jager J; Tromp A; Hooymans JM; Reitsma WD; Smit AJ
    Ophthalmologica; 1997; 211(4):209-13. PubMed ID: 9216008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term kinetic vitreous fluorophotometry in normal and diabetic subjects.
    Knudsen LL; Olsen T; Nielsen-Kudsk F
    Acta Ophthalmol (Copenh); 1992 Oct; 70(5):570-7. PubMed ID: 1471478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Permeability of the blood-retinal barrier and the blood-aqueous barrier in type I diabetes without diabetic retinopathy: simultaneous evaluation with fluorophotometry.
    Schalnus R; Ohrloff C; Jungmann E; Maass K; Rinke S; Wagner A
    Ger J Ophthalmol; 1993 Aug; 2(4-5):202-6. PubMed ID: 8220099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitreous fluorophotometry and changes in blood-retinal barrier permeability induced by bendazac lysine.
    Nuzzi G; Venturini I; De Gregorio M; Arsenio L; Maraini G
    Acta Ophthalmol Scand; 1997 Feb; 75(1):41-3. PubMed ID: 9088399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping retinal fluorescein leakage with confocal scanning laser fluorometry of the human vitreous.
    Lobo CL; Bernardes RC; Santos FJ; Cunha-Vaz JG
    Arch Ophthalmol; 1999 May; 117(5):631-7. PubMed ID: 10326960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The blood-ocular barrier in type I diabetes without diabetic retinopathy: permeability measurements using fluorophotometry.
    Schalnus R; Ohrloff C
    Ophthalmic Res; 1995; 27 Suppl 1():116-23. PubMed ID: 8577448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oscillatory potentials and permeability of the blood-retinal barrier in noninsulin-dependent diabetic patients without retinopathy.
    Yoshida A; Kojima M; Ogasawara H; Ishiko S
    Ophthalmology; 1991 Aug; 98(8):1266-71. PubMed ID: 1923365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitreous fluorophotometry in insulin-dependent diabetes mellitus. Correlation with microalbuminuria and diastolic blood pressure.
    Jackson WE; Chase HP; Garg SK; Bartlett DA; Hoops S; Harris S; Marshall G; Ishimoto BM
    Arch Ophthalmol; 1990 Dec; 108(12):1733-5. PubMed ID: 2256845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescein transport across the human blood-retina barrier in the direction vitreous to blood. Quantitative assessment in vivo.
    Engler CB; Sander B; Larsen M; Dalgaard P; Lund-Andersen H
    Acta Ophthalmol (Copenh); 1994 Dec; 72(6):655-62. PubMed ID: 7747570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitreous fluorophotometry in patients with no or minimal diabetic retinopathy.
    Chahal P; Fallon TJ; Jennings SJ; Chowienczyk PJ; Kohner EM
    Diabetes Care; 1986; 9(2):134-9. PubMed ID: 3698779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitreous fluorophotometry in juvenile diabetics with and without retinopathy in relation to metabolic control: insulin antibodies and c-peptide levels.
    Kernell A; Ludvigsson J; Finnström K
    Acta Ophthalmol (Copenh); 1990 Aug; 68(4):415-20. PubMed ID: 2220357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posterior vitreous fluorophotometry in diabetic patients with minimal or no retinopathy.
    Roy MS; Podgor MJ; Bungay P; Grunberger G; Carl J; Ellis D
    Retina; 1987; 7(3):170-6. PubMed ID: 3423432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of permeability in blood-retinal barrier.
    Kojima M; Yoshida A; Ishiko S; Tanaka K
    Hokkaido Igaku Zasshi; 1990 Jul; 65(4):419-27. PubMed ID: 2227794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posterior vitreous fluorophotometry. II. Comparison of diabetic patients and controls with the use of a new analysis procedure.
    Roy MS; Bungay PM; Bonner RF
    Arch Ophthalmol; 1989 Sep; 107(9):1328-33. PubMed ID: 2675803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and metabolic factors associated with the blood retinal barrier permeability in insulin dependent diabetes mellitus without retinopathy.
    Benitez del Castillo JM; Castillo A; Fernandez PC; Garcia Sanchez J
    Doc Ophthalmol; 1993; 84(2):127-33. PubMed ID: 8299503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihistamines reduce blood-retinal barrier permeability in type I (insulin-dependent) diabetic patients with nonproliferative retinopathy. A pilot study.
    Gardner TW; Eller AW; Friberg TR; D'Antonio JA; Hollis TM
    Retina; 1995; 15(2):134-40. PubMed ID: 7624601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anterior chamber and vitreous fluorescein kinetics in normal and diabetic subjects.
    Knudsen LL; Nielsen-Kudsk F
    Acta Ophthalmol Scand; 1998 Aug; 76(4):396-400. PubMed ID: 9716323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axial and para-axial fluorophotometry in glaucoma simplex.
    Szymanski A; Gierek-Lapinska A; Koziak M; Gierek-Kalicka S
    Int Ophthalmol; 1992 Sep; 16(4-5):283-5. PubMed ID: 1428558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of blood-retinal barrier permeability: a reproducibility study in normal eyes.
    Chahal PS; Chowienczyk PJ; Kohner EM
    Invest Ophthalmol Vis Sci; 1985 Jul; 26(7):977-82. PubMed ID: 4008212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fluorophotometry of the vitreous body in diabetics without retinopathy or with minimal retinopathy].
    Bordat B; Guirgis IR; Manderscheid JC
    J Fr Ophtalmol; 1990; 13(6-7):343-7. PubMed ID: 2290006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.